Suppr超能文献

到2000年生物技术业务的战略考量。

Strategic considerations for the biotechnology business to the year 2000.

作者信息

Cometta S

机构信息

SRI International, Biotechnology Business Consulting, Menlo Park, CA.

出版信息

Arzneimittelforschung. 1989 Aug;39(8):929-34.

PMID:2818683
Abstract

Biotechnology is multidisciplinary in nature and affects a variety of industry sectors. Often, the success of biotechnology ventures depends on strategic alliances. However, up to now, with few exceptions, the only major products based on modern biotechnology that have been commercialized have been pharmaceutical ones, and that trend is likely to continue. Although some of the early promises of the bioindustry have been fulfilled, many more have yet to be substantiated.

摘要

生物技术本质上是多学科的,并影响着多个行业领域。通常,生物技术企业的成功取决于战略联盟。然而,到目前为止,除了少数例外,基于现代生物技术的唯一已商业化的主要产品一直是制药产品,而且这种趋势可能会持续下去。尽管生物产业早期的一些承诺已经实现,但还有更多承诺有待证实。

相似文献

3
Innovation drives success in Switzerland's biotech scene.创新推动瑞士生物技术领域走向成功。
Drug Discov Today. 2005 Oct 15;10(20):1342-5. doi: 10.1016/S1359-6446(05)03605-6.
8
Early-stage returns?早期回报?
Nat Biotechnol. 2006 Nov;24(11):1335-40. doi: 10.1038/nbt1106-1335.
10
Fresh horizons South Korea.
Nature. 2002 Dec 12;420(6916):4-5. doi: 10.1038/nj6916-04a.

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验